Molecule One is a tech-bio company based in Warsaw, Poland on a mission to solve the unpredictability of organic chemistry so drugs can be made faster.
We leverage our diverse background in organic chemistry, artificial intelligence and software to build solutions that speak to and empower chemists.
To date Molecule.one raised $5m in pre-seed & seed rounds, has worked with 6 of the world's largest biopharma companies, and in 2019 was the first CEE startup ever to launch at Startup Battlefield TechCrunch Disrupt San Francisco.
Molecule One is a fast-growing company. If you want to work with us to make our vision happen please get in touch.
We are a collection of talented, ambitious, and innovative people working to improve drug discovery.
"Solve the unpredictability of chemical synthesis and you will transform the way drugs are made."
Piotr Byrski, CEO
Co-founders Piotr Byrski, MD (L) , and Paweł Włodarczyk-Pruszyński, MD (R)
We are a team of 23 experts with a background in academia and expertise in AI and chemistry.
What connects us on the molecular level is that we are all driven by the company’s mission: to help make medicines faster.
Our unique culture fosters diverse thinking and leverages the expertise of all team members. We believe in collaboration and working together towards a common goal, rather than in silos or hierarchy.
To continually improve and innovate, we hold internal chemistry lessons and machine learning seminars, as well as collaborate with external consultants who bring valuable knowledge and experience to the table.
At the core of our company is the scientific method, which allows our team to find the best solutions by taking risks and experimenting.
We prioritize focused work time and minimize mandatory meetings to allow for maximum productivity. Additionally, we encourage our employees to work on projects of their own choosing, in pursuit of their individual passions and interests.